Zobrazeno 1 - 10
of 269
pro vyhledávání: '"New-onset diabetes after transplantation"'
Publikováno v:
Український Журнал Нефрології та Діалізу, Iss 2(82) (2024)
New-onset diabetes after transplantation (NODAT) is a serious complication following solid organ transplantation. NODAT occurs in 2.5% to 40% of all solid organ transplant recipients. The identification of high-risk patients and the implementation of
Externí odkaz:
https://doaj.org/article/0e3a3b0f521c409eaf12be9f5fe027d1
Autor:
Grzegorz Rudzki, Kinga Knop-Chodyła, Zuzanna Piasecka, Anna Kochanowska-Mazurek, Aneta Głaz, Ewelina Wesołek-Bielaska, Magdalena Woźniak
Publikováno v:
Pharmaceuticals, Vol 17, Iss 8, p 987 (2024)
Kidney transplantation is the most effective treatment for end-stage renal failure but is associated with complications, including post-transplant diabetes mellitus (PTDM). It affects the quality of life and survival of patients and the transplanted
Externí odkaz:
https://doaj.org/article/670d8ebec97545948706b5035aa989df
Autor:
Fatmah A. Bakhdar, MSc, Hala S. Abdel kawy, PhD, Rania M. Magadmi, PhD, Eman A. El-Kordy, PhD, Abdulhakeem S. Alamri, PhD
Publikováno v:
Journal of Taibah University Medical Sciences, Vol 18, Iss 1, Pp 9-18 (2023)
الملخص: أهداف البحث: يعتبر مثبط المناعة (التاكروليموس) أهم مسبب للإصابة بنوع السكري الجديد ما بعد زراعة الكلى. تهدف الدراسة لتقييم فعالية
Externí odkaz:
https://doaj.org/article/5181aa960145458c84a4c4eb9abab3cf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Heliyon, Vol 9, Iss 4, Pp e15536- (2023)
Treatment using the immunosuppressive drug tacrolimus (TAC) is related to new-onset diabetes after transplantation (NODAT). Previous studies focused mainly on islet β cells in the diabetogenic effect of TAC. Herein, we revealed that NODAT was probab
Externí odkaz:
https://doaj.org/article/5a3f349dbe3943a3846b810414401dc4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Acta Clinica Croatica, Vol 60., Iss Supplement 1, Pp 86-95 (2021)
New-onset diabetes after transplantation (NODAT) is a frequent and severe complication after renal transplantation. It is diagnosed according to standard criteria for type 2 diabetes. Risk factors for NODAT are non-modifiable (non-white ethnicity,
Externí odkaz:
https://doaj.org/article/b848ed4200df4f20b671ad26c3c799af
Autor:
Aravinth Kumar Rajendiran, Dhanapriya Jeyachandran, Natarajan Gopalakrishnan, Venkatesh Arumugam, Dineshkumar Thanigachalam, Sakthirajan Ramanathan
Publikováno v:
Indian Journal of Transplantation, Vol 15, Iss 2, Pp 125-130 (2021)
Aim: The aim was to study the clinical characteristics of postrenal transplant cytomegalovirus (CMV) infection and analyze its risk factors and its impact on graft and patient survival. Materials and Methods: We reviewed medical records of 739 renal
Externí odkaz:
https://doaj.org/article/eac837c3011a46bb9bc734621b17bf81
Publikováno v:
Терапевтический архив, Vol 92, Iss 12, Pp 137-141 (2020)
Aim.To analyze the modes of immunosuppressive therapy as a risk factor for new-onset diabetes after transplantation (NODAT) in kidney recipients. Materials and methods.The retrospective analysis included data from 1367 recipients (755 men and 612
Externí odkaz:
https://doaj.org/article/45d02884e2574e08bf635813198b8330
Autor:
Ahmed E.S El Boghdady, Mervat E.S El Wakeel, Dina M Abaza, Khaled M Ewada, Hisham A El Bardissy
Publikováno v:
Al-Azhar Assiut Medical Journal, Vol 18, Iss 4, Pp 453-458 (2020)
Background Up to 50% of renal transplant recipients can experience diabetes mellitus (DM) and insulin resistance (IR). Both metabolic complications significantly increase the risk of progressive loss of renal function, cardiovascular morbidity, and d
Externí odkaz:
https://doaj.org/article/631cd0ef329b457f9d7dab07a0455bfd